Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries I-Mab ADR (NQ: IMAB ) 1.705 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.705 Bid (Size) 1.660 (15) Ask (Size) 1.880 (2) Prev. Close 1.705 Today's Range 1.705 - 1.705 52wk Range 1.170 - 3.170 Shares Outstanding 185,613,662 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million June 08, 2024 Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent... Via Talk Markets 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga Performance YTD -24.22% -24.22% 1 Month -2.01% -2.01% 3 Month -8.82% -8.82% 6 Month +5.90% +5.90% 1 Year -45.18% -45.18% More News Read More 12 Health Care Stocks Moving In Tuesday's Intraday Session June 04, 2024 Via Benzinga (IMAB) - Analyzing I-MAB's Short Interest May 07, 2024 Via Benzinga NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday March 18, 2024 Via Benzinga Looking Into I-MAB's Recent Short Interest February 07, 2024 Via Benzinga Expert Ratings for I-MAB September 25, 2023 Via Benzinga Where I-MAB Stands With Analysts September 05, 2023 Via Benzinga Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million February 11, 2024 Via Talk Markets 12 Health Care Stocks Moving In Friday's After-Market Session December 15, 2023 Via Benzinga Week In Review: Two China Biopharmas Announce Billion Dollar Deals October 14, 2023 Via Talk Markets Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq September 30, 2023 Via Talk Markets Topics Initial Public Offering Exposures Securities Market Analyst Ratings for I-MAB August 18, 2023 Via Benzinga 5 Analysts Have This to Say About I-MAB June 05, 2023 Via Benzinga I-Mab Reveals Promising Results in Phase 1b/2 Study for Advanced Non-Small Cell Lung Cancer Treatment May 26, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 28, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday September 28, 2023 Via InvestorPlace Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal September 02, 2023 Via Talk Markets 7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole August 25, 2023 Via InvestorPlace Why Is TRACON Pharma (TCON) Stock Down 51% Today? April 25, 2023 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 25, 2023 Via InvestorPlace Last Day Of Q1 March 31, 2023 Via Benzinga ImmuneOnco Banks On Cutting-edge Cancer Drugs To Attract IPO Cash March 31, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Monday March 27, 2023 Via Benzinga Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session February 06, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
